Zusammenfassung
Der intrauterine Fruchttod kann verschiedene Ursachen haben. Es werden Ergebnisse aus Studien zum Zusammenhang zwischen dem intrauterinen Fruchttod und hereditären sowie erworbenen Thrombophilien dargestellt. Darüber hinaus werden prophylaktische Optionen diskutiert.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Auf die Bedeutung, Häufigkeit, Komplikationen und mögliche Therapieoptionen bei Vorliegen einer maternalen Thrombophilie wurde bereits in Kap. 17 in Hinblick auf das Auftreten habitueller Frühaborte eingegangen.
Literatur
Alfirevic Z, Roberts D, Martlew V (2002) How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review Eur J Obstet Gynecol Reprod Biol 101: 6–14
Aracic N, Roje D, Drmic Hofman I, Capkun V, Stefanovic V (2015) Low molecular weight heparin treatment and impact of inherited thrombophilia type in pregnancies with previous adverse outcome. J Matern Fetal Neonatal Med 28: 306–310
Beeksma FA, Erwich JJ, Khong TY (2012) Placental fetal vascular thrombosis lesions and maternal thrombophilia. Pathology 44: 24–28
Bertolaccini ML, Mepani K, Sanna G, Hughes GR, Khamashta MA (2007) Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus. Ann Rheum Dis 66: 533–536
Bretelle F, Arnoux D, Shojai R, D'Ercole C, Sampol J, Dignat F, Camoin-Jau L (2005) Protein Z in patients with pregnancy complications. Am J Obstet Gynecol 193: 1698–1702
Frias AE Jr, Luikenaar RA, Sullivan AE, Lee RM, Porter TF, Branch DW, Silver RM (2004) Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol 104: 521–526
Ghidini A (2014) Overview of low molecular weight heparin for preventative treatment of adverse obstetric outcomes related to abnormal placentation. Prenat Diagn 34: 649–654
Hansen AT, Schmidt M, Horváth-Puhó E, Pedersen L, Rothman KJ, Hvas AM, Sørensen HT (2015) Preconception venous thromboembolism and placenta-mediated pregnancy complications. J Thromb Haemost 13: 1635–1641
Hvas AM, Ingerslev J, Salvig JD (2009) Thrombophilia risk factors are associated with intrauterine foetal death and pregnancy-related venous thromboembolism. Scand J Clin Lab Invest 69: 288–294
James AH, Jamison MG (2007) Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. J Thromb Haemost 5: 1165–1169
de Jong PG, Goddijn M, Middeldorp S (2013) Antithrombotic therapy for pregnancy loss. Hum Reprod Update 19: 656–673
Kumar M, Mehta P (1994) Congenital coagulopathies and pregnancy: report of four pregnancies in a factor X-deficient woman. Am J Hematol 46: 241–244
Kupferminc MJ, Rimon E, Many A, Sharon M, Lessing JB, Gamzu R (2011) Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications. J Matern Fetal Neonatal Med 24: 1042–1045
Martinelli I, Ruggenenti P, Cetin I, Pardi G, Perna A, Vergani P, Acaia B, Facchinetti F, La Sala GB, Bozzo M, Rampello S, Marozio L, Diadei O, Gherardi G, Carminati S, Remuzzi G, Mannucci PM (2012) Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood 119: 3269–3275
Mitic G, Kovac M, Povazan L, Magic Z, Djordjevic V, Salatic I, Mitic I, Novakov-Mikic A (2010) Inherited thrombophilia is associated with pregnancy losses that occur after 12th gestational week in Serbian population. Clin Appl Thromb Hemost 16: 435–439
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4: 295–306
Mutlu I, Mutlu MF, Biri A, Bulut B, Erdem M, Erdem A (2015) Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history. Blood Coagul Fibrinolysis 26: 267–273
Rai R, Cohen H, Dave M, Regan L (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314: 253–257
Rawlinson WD, Hall B, Jones CA, Jeffery HE, Arbuckle SM, Graf N, Howard J, Morris JM (2008) Viruses and other infections in stillbirth: what is the evidence and what should we be doing? Pathology 40: 149–160
Rey E, Kahn SR, David M, Shrier I (2003) Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361: 901–908
Rimon E, Ascher-Landsberg J, Carmi N, Many A, Deutsch V, Kupferminc MJ (2012) Severe pregnancy complications are associated with elevated factor VIII plasma activity. Blood Coagul Fibrinolysis 23: 184–188
Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Regan L, Greer IA (2006) The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 132: 171–196
Rodger MA, Carrier M, Le Gal G, Martinelli I, Perna A, Rey E, de Vries JI, Gris JC (2014) Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications. Blood 123: 822–828
Rodger MA, Hague WM, Kingdom J, Kahn SR, Karovitch A, Sermer M, Clement AM, Coat S, Chan WS, Said J, Rey E, Robinson S, Khurana R, Demers C, Kovacs MJ, Solymoss S, Hinshaw K, Dwyer J, Smith G, McDonald S, Newstead-Angel J, McLeod A, Khandelwal M, Silver RM, Le Gal G, Greer IA, Keely E, Rosene-Montella K, Walker M, Wells PS (2014) Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. Lancet 384: 1673–1683
Rogenhofer N, Bohlmann MK, Beuter-Winkler P, Würfel W, Rank A, Thaler CJ, Toth B (2014) Prevention, management and extent of adverse pregnancy outcomes in women with hereditary Antithrombin deficiency. Ann Hematol 93: 385–392
Silver RM (2007) Fetal death. Obstet Gynecol 109: 153–167
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bohlmann, M.K. (2017). Gerinnungsphysiologie bei Totgeburten. In: Toth, B. (eds) Fehlgeburten Totgeburten Frühgeburten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50424-6_42
Download citation
DOI: https://doi.org/10.1007/978-3-662-50424-6_42
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-50423-9
Online ISBN: 978-3-662-50424-6
eBook Packages: Medicine (German Language)